Home > Insider Trading > Filing (0001179110-20-005520)

Filing Details

Accession Number:: 0001179110-20-005520
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-06 16:02:49
Reporting Period:: 2020-05-04

Accepted Time:: 2020-05-06 16:02:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1017832	P Martin Sutter	22 Cherry Hill Drive Danvers MA 01923		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.01 Par Value	Acquisiton	2020-05-04	12,000	$9.99	200,939	No	4	M	Direct
Common Stock, $0.01 Par Value	Disposition	2020-05-04	2,290	$178.44	198,649	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2020-05-04	1,400	$179.35	197,249	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2020-05-04	1,100	$180.39	196,149	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2020-05-04	6,584	$181.46	189,565	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2020-05-04	626	$182.14	188,939	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-05-04	12,000	$0.00	12,000	$9.99

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2011-08-10	2020-08-11	No	4	M	Direct

Footnotes

Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
Exercise of stock options in advance of the expiration of ten year contractual term of the underlying awards.
Sale of common stock solely for the payment of tax liability associated with the exercise of options.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $177.9600 and $178.8900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $178.9600 and $179.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $180.0000 and $180.9050. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $180.9900 and $181.9300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $181.9900 and $182.1900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.